Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06070766 · ClinicalTrials.gov registry record
RIVER At Home Ketamine Protocols
A clinical trial of Chronic Pain and Major Depressive Disorder, sponsored by RIVER Foundation.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 2
- Study locations
NCT06070766 is a study of Chronic Pain and Major Depressive Disorder that is actively recruiting participants, run by RIVER Foundation. The registered enrollment target is 50,000 participants, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06070766, a study of Chronic Pain and Major Depressive Disorder, is actively recruiting participants, sponsored by RIVER Foundation.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multiple site studies with the recruitment of other sub-investigators and sites. It's sobering to consider how chronic illness makes us more vulnerable to suicidal thoughts and behavior. However, the existence of multiple risk factors also means that there are numerous ways to intervene. Addressing and improving even one risk area will reverberate and improve other areas and the quality of life. RIVER Foundation is completing a 500-participant pilot study researching the safety of oral and nasal ketamine at home with no therapy. The pilot study examined three psychological scales: P.H.Q. 9, G.A.D. 7, and PCL5 scores. The interim report will be available in Nov 2023 with a final report in June 2024. The lack of knowledge for the average medical practitioner makes ketamine a boutique medicine, often costly and unaffordable to those in need. Yet daily medical providers are eliminating ketamine as a choice in the treatment of chronic conditions. The pilot study demonstrated the who, and where. The who, was adults with a chronic condition. The pilot study demonstrated the majority of those who could use ketamine are not receiving it due to cost. According to the 500-participant study, ketamine is safe and effective for at-home use thus demonstrating the where (at home with no supervision).
Conditions Studied
Interventions
- DRUG Ketamine
Study Locations (2)
Montana
- RIVER Foundation - Bigfork
- RIVER Telehealth - Helena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2029-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06070766
The ClinicalTrials.gov registry entry for NCT06070766 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher). The listed sponsor is RIVER Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.
NCT06070766 reports 2 study locations spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT06070766 about?
NCT06070766 is a clinical study titled "RIVER At Home Ketamine Protocols". Multiple site studies with the recruitment of other sub-investigators and sites. It's sobering to consider how chronic illness makes us more vulnerable to suicidal thoughts and behavior. However, the existence of multiple risk factors also means that there are numerous ways to intervene. Addressing ...
What is the current status of trial NCT06070766?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2023-10-01. Estimated completion is 2029-04-01.
What conditions does trial NCT06070766 study?
This clinical trial studies the following conditions: Chronic Pain, Major Depressive Disorder, Post Traumatic Stress Disorder, Anxiety Disorders, Chronic Disease.
What interventions are being tested in trial NCT06070766?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT06070766?
This trial is sponsored by RIVER Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06070766 being conducted?
This trial has 2 study locations across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.